Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rosetta Omics has developed a patented platform that combines spatial multiomics profiling of tumor biopsies with advanced AI algorithms to deliver highly sensitive and specific predictions about optimal first-line therapies in oncology. Their solution is being validated clinically, starting with liver and colon cancers. The company collaborates closely with hospitals across France and Europe, as well as global partners in the USA, Singapore, and the Middle East. They are also developing companion diagnostics for patient stratification in clinical trials.[3][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rosetta Omics.